Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Choose from a selection of modern and traditional designs in single or twin packs to support type 1 diabetes research this Christmas. Shop online and get fast delivery.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
This World Diabetes Day, we’re inviting you to celebrate by wearing your most joyful, whimsical and downright wonderful outfits.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > News & events > News > JDRF UK appoints Terence Lovell as Fundraising and Engagement Director
We are delighted to welcome Terence Lovell as Director of Fundraising and Engagement. Terence has worked in the not-for-profit sector for over 20 years. He built his career at Barnardo’s, Save the Children where he was Deputy Director for Supporters and Communities, and Teach First where he was Director of Development.
Most recently, Terence was Chief Engagement and Marketing Officer at the blood cancer charity Anthony Nolan. He was responsible for increasing voluntary income, building awareness and growth in the stem cell donor register, along with driving digital transformation and organisational strategy development.
Terence has worked in the not-for-profit sector for over 20 years. He built his career at Barnardo’s, Save the Children where he was Deputy Director for Supporters and Communities, and Teach First where he was Director of Development.
He said, “I’m absolutely delighted to be joining JDRF UK as the new Director of Fundraising and Engagement.
“I’m passionate about playing my role in eradicating type 1 diabetes by funding the life-changing research breakthroughs here in the UK and internationally.
“It’s a golden age in type 1 diabetes research progress and I’m excited to be playing such a fundamental part in JDRF’s mission.”
JDRF UK CEO Karen Addington said, “Terence has significant breadth and depth of experience in income generation and supporter engagement.
“We are delighted to welcome him to JDRF UK at this tremendously exciting point in our development where we are so significantly growing in income and impact to prevent, treat and cure type 1 diabetes.”
Breakthrough T1D will continue JDRF's journey, accelerating breakthroughs in research, breakthroughs in access to treatments, and bringing the T1D community together to help everyone make their own personal breakthroughs.
The leading global type 1 diabetes charity, JDRF International (JDRF) is proud to unveil its new brand and name, Breakthrough T1D. The new name embodies its mission to cure and treat type 1 diabetes (T1D), while supporting everyone who lives with the condition.
Last night JDRF teamed up with the Royal Osteoporosis Society to host a charity carol concert at St Paul’s Cathedral. The event featured a lineup of familiar faces, including The Rt. Hon Theresa May MP and Derrick Evans MBE.
Daniel Doherty has received the UK Medical Research Council (MRC) Clinical Research Training Fellowship, which will be co-funded by JDRF for the first time.
Don’t miss out on the latest research, inspiring stories, tech news, upcoming events, and handy information on living well with type 1. Join us now and receive it all straight to your inbox.
It’s thanks to your dedication that we have funded great progress in type 1 cure, treatment and prevention research. Help us to continue our vital research.